Cargando…

Is Blood Loss Greater in Elderly Patients under Antiplatelet or Anticoagulant Medication for Cervical Spine Injury Surgery? A Japanese Multicenter Survey

INTRODUCTION: In elderly patients with cervical spinal cord injury, comorbidities such as cardiovascular and cerebrovascular diseases are common, with frequent administration of antiplatelet/anticoagulant (APAC) drugs. Such patients may bleed easily or unexpectedly during surgery despite prior withd...

Descripción completa

Detalles Bibliográficos
Autores principales: Uehara, Masashi, Ikegami, Shota, Takizawa, Takashi, Oba, Hiroki, Yokogawa, Noriaki, Sasagawa, Takeshi, Ando, Kei, Nakashima, Hiroaki, Segi, Naoki, Funayama, Toru, Eto, Fumihiko, Yamaji, Akihiro, Watanabe, Kota, Nori, Satoshi, Takeda, Kazuki, Furuya, Takeo, Orita, Sumihisa, Nakajima, Hideaki, Yamada, Tomohiro, Hasegawa, Tomohiko, Terashima, Yoshinori, Hirota, Ryosuke, Suzuki, Hidenori, Imajo, Yasuaki, Tonomura, Hitoshi, Sakata, Munehiro, Hashimoto, Ko, Onoda, Yoshito, Kawaguchi, Kenichi, Haruta, Yohei, Suzuki, Nobuyuki, Kato, Kenji, Uei, Hiroshi, Sawada, Hirokatsu, Nakanishi, Kazuo, Misaki, Kosuke, Terai, Hidetomi, Tamai, Koji, Shirasawa, Eiki, Inoue, Gen, Kakutani, Kenichiro, Kakiuchi, Yuji, Kiyasu, Katsuhito, Tominaga, Hiroyuki, Tokumoto, Hiroto, Iizuka, Yoichi, Takasawa, Eiji, Akeda, Koji, Takegami, Norihiko, Funao, Haruki, Oshima, Yasushi, Kaito, Takashi, Sakai, Daisuke, Yoshii, Toshitaka, Ohba, Tetsuro, Otsuki, Bungo, Seki, Shoji, Miyazaki, Masashi, Ishihara, Masayuki, Okada, Seiji, Aoki, Yasuchika, Harimaya, Katsumi, Murakami, Hideki, Ishii, Ken, Ohtori, Seiji, Imagama, Shiro, Kato, Satoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society for Spine Surgery and Related Research 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9381072/
https://www.ncbi.nlm.nih.gov/pubmed/36051672
http://dx.doi.org/10.22603/ssrr.2021-0183
_version_ 1784769002734616576
author Uehara, Masashi
Ikegami, Shota
Takizawa, Takashi
Oba, Hiroki
Yokogawa, Noriaki
Sasagawa, Takeshi
Ando, Kei
Nakashima, Hiroaki
Segi, Naoki
Funayama, Toru
Eto, Fumihiko
Yamaji, Akihiro
Watanabe, Kota
Nori, Satoshi
Takeda, Kazuki
Furuya, Takeo
Orita, Sumihisa
Nakajima, Hideaki
Yamada, Tomohiro
Hasegawa, Tomohiko
Terashima, Yoshinori
Hirota, Ryosuke
Suzuki, Hidenori
Imajo, Yasuaki
Tonomura, Hitoshi
Sakata, Munehiro
Hashimoto, Ko
Onoda, Yoshito
Kawaguchi, Kenichi
Haruta, Yohei
Suzuki, Nobuyuki
Kato, Kenji
Uei, Hiroshi
Sawada, Hirokatsu
Nakanishi, Kazuo
Misaki, Kosuke
Terai, Hidetomi
Tamai, Koji
Shirasawa, Eiki
Inoue, Gen
Kakutani, Kenichiro
Kakiuchi, Yuji
Kiyasu, Katsuhito
Tominaga, Hiroyuki
Tokumoto, Hiroto
Iizuka, Yoichi
Takasawa, Eiji
Akeda, Koji
Takegami, Norihiko
Funao, Haruki
Oshima, Yasushi
Kaito, Takashi
Sakai, Daisuke
Yoshii, Toshitaka
Ohba, Tetsuro
Otsuki, Bungo
Seki, Shoji
Miyazaki, Masashi
Ishihara, Masayuki
Okada, Seiji
Aoki, Yasuchika
Harimaya, Katsumi
Murakami, Hideki
Ishii, Ken
Ohtori, Seiji
Imagama, Shiro
Kato, Satoshi
author_facet Uehara, Masashi
Ikegami, Shota
Takizawa, Takashi
Oba, Hiroki
Yokogawa, Noriaki
Sasagawa, Takeshi
Ando, Kei
Nakashima, Hiroaki
Segi, Naoki
Funayama, Toru
Eto, Fumihiko
Yamaji, Akihiro
Watanabe, Kota
Nori, Satoshi
Takeda, Kazuki
Furuya, Takeo
Orita, Sumihisa
Nakajima, Hideaki
Yamada, Tomohiro
Hasegawa, Tomohiko
Terashima, Yoshinori
Hirota, Ryosuke
Suzuki, Hidenori
Imajo, Yasuaki
Tonomura, Hitoshi
Sakata, Munehiro
Hashimoto, Ko
Onoda, Yoshito
Kawaguchi, Kenichi
Haruta, Yohei
Suzuki, Nobuyuki
Kato, Kenji
Uei, Hiroshi
Sawada, Hirokatsu
Nakanishi, Kazuo
Misaki, Kosuke
Terai, Hidetomi
Tamai, Koji
Shirasawa, Eiki
Inoue, Gen
Kakutani, Kenichiro
Kakiuchi, Yuji
Kiyasu, Katsuhito
Tominaga, Hiroyuki
Tokumoto, Hiroto
Iizuka, Yoichi
Takasawa, Eiji
Akeda, Koji
Takegami, Norihiko
Funao, Haruki
Oshima, Yasushi
Kaito, Takashi
Sakai, Daisuke
Yoshii, Toshitaka
Ohba, Tetsuro
Otsuki, Bungo
Seki, Shoji
Miyazaki, Masashi
Ishihara, Masayuki
Okada, Seiji
Aoki, Yasuchika
Harimaya, Katsumi
Murakami, Hideki
Ishii, Ken
Ohtori, Seiji
Imagama, Shiro
Kato, Satoshi
author_sort Uehara, Masashi
collection PubMed
description INTRODUCTION: In elderly patients with cervical spinal cord injury, comorbidities such as cardiovascular and cerebrovascular diseases are common, with frequent administration of antiplatelet/anticoagulant (APAC) drugs. Such patients may bleed easily or unexpectedly during surgery despite prior withdrawal of APAC medication. Few reports have examined the precise relationship between intraoperative blood loss and history of APAC use regarding surgery for cervical spine injury in the elderly. The present multicenter database survey aimed to answer the question of whether the use of APAC drugs affected the amount of intraoperative blood loss in elderly patients with cervical spinal cord trauma. METHODS: The case histories of 1512 patients with cervical spine injury at 33 institutes were retrospectively reviewed. After excluding cases without spinal surgery or known blood loss volume, 797 patients were enrolled. Blood volume loss was the outcome of interest. We calculated propensity scores using the inverse probability of treatment weighting (IPTW) method. As an alternative sensitivity analysis, linear mixed model analyses were conducted as well. RESULTS: Of the 776 patients (mean age: 75.1±6.4 years) eligible for IPTW calculation, 157 (20.2%) were taking APAC medications before the injury. After weighting, mean estimated blood loss was 204 mL for non-APAC patients and 215 mL for APAC patients. APAC use in elderly patients was not significantly associated with surgical blood loss according to the IPTW method with propensity scoring or linear mixed model analyses. Thus, it appeared possible to perform surgery expecting comparable blood loss in APAC and non-APAC cases. CONCLUSIONS: This multicenter study revealed no significant increase in surgical blood loss in elderly patients with cervical trauma taking APAC drugs. Surgeons may be able to prioritize patient background, complications, and preexisting conditions over APAC use before injury when examining the surgical indications for cervical spine trauma in the elderly.
format Online
Article
Text
id pubmed-9381072
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The Japanese Society for Spine Surgery and Related Research
record_format MEDLINE/PubMed
spelling pubmed-93810722022-08-31 Is Blood Loss Greater in Elderly Patients under Antiplatelet or Anticoagulant Medication for Cervical Spine Injury Surgery? A Japanese Multicenter Survey Uehara, Masashi Ikegami, Shota Takizawa, Takashi Oba, Hiroki Yokogawa, Noriaki Sasagawa, Takeshi Ando, Kei Nakashima, Hiroaki Segi, Naoki Funayama, Toru Eto, Fumihiko Yamaji, Akihiro Watanabe, Kota Nori, Satoshi Takeda, Kazuki Furuya, Takeo Orita, Sumihisa Nakajima, Hideaki Yamada, Tomohiro Hasegawa, Tomohiko Terashima, Yoshinori Hirota, Ryosuke Suzuki, Hidenori Imajo, Yasuaki Tonomura, Hitoshi Sakata, Munehiro Hashimoto, Ko Onoda, Yoshito Kawaguchi, Kenichi Haruta, Yohei Suzuki, Nobuyuki Kato, Kenji Uei, Hiroshi Sawada, Hirokatsu Nakanishi, Kazuo Misaki, Kosuke Terai, Hidetomi Tamai, Koji Shirasawa, Eiki Inoue, Gen Kakutani, Kenichiro Kakiuchi, Yuji Kiyasu, Katsuhito Tominaga, Hiroyuki Tokumoto, Hiroto Iizuka, Yoichi Takasawa, Eiji Akeda, Koji Takegami, Norihiko Funao, Haruki Oshima, Yasushi Kaito, Takashi Sakai, Daisuke Yoshii, Toshitaka Ohba, Tetsuro Otsuki, Bungo Seki, Shoji Miyazaki, Masashi Ishihara, Masayuki Okada, Seiji Aoki, Yasuchika Harimaya, Katsumi Murakami, Hideki Ishii, Ken Ohtori, Seiji Imagama, Shiro Kato, Satoshi Spine Surg Relat Res Original Article INTRODUCTION: In elderly patients with cervical spinal cord injury, comorbidities such as cardiovascular and cerebrovascular diseases are common, with frequent administration of antiplatelet/anticoagulant (APAC) drugs. Such patients may bleed easily or unexpectedly during surgery despite prior withdrawal of APAC medication. Few reports have examined the precise relationship between intraoperative blood loss and history of APAC use regarding surgery for cervical spine injury in the elderly. The present multicenter database survey aimed to answer the question of whether the use of APAC drugs affected the amount of intraoperative blood loss in elderly patients with cervical spinal cord trauma. METHODS: The case histories of 1512 patients with cervical spine injury at 33 institutes were retrospectively reviewed. After excluding cases without spinal surgery or known blood loss volume, 797 patients were enrolled. Blood volume loss was the outcome of interest. We calculated propensity scores using the inverse probability of treatment weighting (IPTW) method. As an alternative sensitivity analysis, linear mixed model analyses were conducted as well. RESULTS: Of the 776 patients (mean age: 75.1±6.4 years) eligible for IPTW calculation, 157 (20.2%) were taking APAC medications before the injury. After weighting, mean estimated blood loss was 204 mL for non-APAC patients and 215 mL for APAC patients. APAC use in elderly patients was not significantly associated with surgical blood loss according to the IPTW method with propensity scoring or linear mixed model analyses. Thus, it appeared possible to perform surgery expecting comparable blood loss in APAC and non-APAC cases. CONCLUSIONS: This multicenter study revealed no significant increase in surgical blood loss in elderly patients with cervical trauma taking APAC drugs. Surgeons may be able to prioritize patient background, complications, and preexisting conditions over APAC use before injury when examining the surgical indications for cervical spine trauma in the elderly. The Japanese Society for Spine Surgery and Related Research 2021-12-27 /pmc/articles/PMC9381072/ /pubmed/36051672 http://dx.doi.org/10.22603/ssrr.2021-0183 Text en Copyright © 2022 by The Japanese Society for Spine Surgery and Related Research https://creativecommons.org/licenses/by-nc-nd/4.0/Spine Surgery and Related Research is an Open Access journal distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Article
Uehara, Masashi
Ikegami, Shota
Takizawa, Takashi
Oba, Hiroki
Yokogawa, Noriaki
Sasagawa, Takeshi
Ando, Kei
Nakashima, Hiroaki
Segi, Naoki
Funayama, Toru
Eto, Fumihiko
Yamaji, Akihiro
Watanabe, Kota
Nori, Satoshi
Takeda, Kazuki
Furuya, Takeo
Orita, Sumihisa
Nakajima, Hideaki
Yamada, Tomohiro
Hasegawa, Tomohiko
Terashima, Yoshinori
Hirota, Ryosuke
Suzuki, Hidenori
Imajo, Yasuaki
Tonomura, Hitoshi
Sakata, Munehiro
Hashimoto, Ko
Onoda, Yoshito
Kawaguchi, Kenichi
Haruta, Yohei
Suzuki, Nobuyuki
Kato, Kenji
Uei, Hiroshi
Sawada, Hirokatsu
Nakanishi, Kazuo
Misaki, Kosuke
Terai, Hidetomi
Tamai, Koji
Shirasawa, Eiki
Inoue, Gen
Kakutani, Kenichiro
Kakiuchi, Yuji
Kiyasu, Katsuhito
Tominaga, Hiroyuki
Tokumoto, Hiroto
Iizuka, Yoichi
Takasawa, Eiji
Akeda, Koji
Takegami, Norihiko
Funao, Haruki
Oshima, Yasushi
Kaito, Takashi
Sakai, Daisuke
Yoshii, Toshitaka
Ohba, Tetsuro
Otsuki, Bungo
Seki, Shoji
Miyazaki, Masashi
Ishihara, Masayuki
Okada, Seiji
Aoki, Yasuchika
Harimaya, Katsumi
Murakami, Hideki
Ishii, Ken
Ohtori, Seiji
Imagama, Shiro
Kato, Satoshi
Is Blood Loss Greater in Elderly Patients under Antiplatelet or Anticoagulant Medication for Cervical Spine Injury Surgery? A Japanese Multicenter Survey
title Is Blood Loss Greater in Elderly Patients under Antiplatelet or Anticoagulant Medication for Cervical Spine Injury Surgery? A Japanese Multicenter Survey
title_full Is Blood Loss Greater in Elderly Patients under Antiplatelet or Anticoagulant Medication for Cervical Spine Injury Surgery? A Japanese Multicenter Survey
title_fullStr Is Blood Loss Greater in Elderly Patients under Antiplatelet or Anticoagulant Medication for Cervical Spine Injury Surgery? A Japanese Multicenter Survey
title_full_unstemmed Is Blood Loss Greater in Elderly Patients under Antiplatelet or Anticoagulant Medication for Cervical Spine Injury Surgery? A Japanese Multicenter Survey
title_short Is Blood Loss Greater in Elderly Patients under Antiplatelet or Anticoagulant Medication for Cervical Spine Injury Surgery? A Japanese Multicenter Survey
title_sort is blood loss greater in elderly patients under antiplatelet or anticoagulant medication for cervical spine injury surgery? a japanese multicenter survey
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9381072/
https://www.ncbi.nlm.nih.gov/pubmed/36051672
http://dx.doi.org/10.22603/ssrr.2021-0183
work_keys_str_mv AT ueharamasashi isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey
AT ikegamishota isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey
AT takizawatakashi isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey
AT obahiroki isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey
AT yokogawanoriaki isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey
AT sasagawatakeshi isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey
AT andokei isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey
AT nakashimahiroaki isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey
AT seginaoki isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey
AT funayamatoru isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey
AT etofumihiko isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey
AT yamajiakihiro isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey
AT watanabekota isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey
AT norisatoshi isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey
AT takedakazuki isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey
AT furuyatakeo isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey
AT oritasumihisa isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey
AT nakajimahideaki isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey
AT yamadatomohiro isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey
AT hasegawatomohiko isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey
AT terashimayoshinori isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey
AT hirotaryosuke isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey
AT suzukihidenori isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey
AT imajoyasuaki isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey
AT tonomurahitoshi isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey
AT sakatamunehiro isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey
AT hashimotoko isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey
AT onodayoshito isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey
AT kawaguchikenichi isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey
AT harutayohei isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey
AT suzukinobuyuki isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey
AT katokenji isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey
AT ueihiroshi isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey
AT sawadahirokatsu isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey
AT nakanishikazuo isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey
AT misakikosuke isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey
AT teraihidetomi isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey
AT tamaikoji isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey
AT shirasawaeiki isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey
AT inouegen isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey
AT kakutanikenichiro isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey
AT kakiuchiyuji isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey
AT kiyasukatsuhito isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey
AT tominagahiroyuki isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey
AT tokumotohiroto isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey
AT iizukayoichi isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey
AT takasawaeiji isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey
AT akedakoji isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey
AT takegaminorihiko isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey
AT funaoharuki isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey
AT oshimayasushi isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey
AT kaitotakashi isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey
AT sakaidaisuke isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey
AT yoshiitoshitaka isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey
AT ohbatetsuro isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey
AT otsukibungo isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey
AT sekishoji isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey
AT miyazakimasashi isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey
AT ishiharamasayuki isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey
AT okadaseiji isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey
AT aokiyasuchika isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey
AT harimayakatsumi isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey
AT murakamihideki isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey
AT ishiiken isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey
AT ohtoriseiji isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey
AT imagamashiro isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey
AT katosatoshi isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey